kabutan

Human Metabolome Technologies, Inc.(6090) Summary

6090
TSE Standard
Human Metabolome Technologies, Inc.
716
JPY
+24
(+3.47%)
Mar 13, 3:30 pm JST
4.49
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
15.3
PBR
2.22
Yield
2.51%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
689 JPY 4.32 USD
Previous Close Mar 12
692 JPY 4.35 USD
High Mar 13, 1:01 pm
732 JPY 4.59 USD
Low Mar 13, 10:45 am
683 JPY 4.29 USD
Volume
15,800
Trading Value
0.01B JPY 0.07M USD
VWAP
713.85 JPY 4.48 USD
Minimum Trading Value
71,600 JPY 449 USD
Market Cap
4.24B JPY 0.03B USD
Number of Trades
66
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly Low
1-Year Average
37
1-Year High Jul 1, 2025
282
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 223,100
Feb 27, 2026 0 229,400
Feb 20, 2026 0 226,300
Feb 13, 2026 0 223,900
Feb 6, 2026 0 220,900
Company Profile
Human Metabolome Technologies, Inc. is a biotech venture company originating from Keio University. The company specializes in metabolite analysis services and biomarker detection.
Sector
Services
Human Metabolome Technologies develops businesses utilizing metabolome analysis and biotechnology. Through its comprehensive metabolite analysis technology using CE-MS method, the company engages in two main business areas: advanced research and development support, and healthcare solutions. In the former, the company provides metabolome analysis services to food, chemical, and pharmaceutical companies, as well as research institutions. In the latter, it supports the development of functional materials.